Skip to main content
. 2005 Sep;167(3):849–858. doi: 10.1016/S0002-9440(10)62056-1

Figure 5.

Figure 5

JAK2 mutation analysis in patients with IM (A), PV (B), or ET (C). The presence of the Val617Phe JAK2 mutation was analyzed by an allele-specific PCR; the 203-bp product is specifically amplified from the mutant allele, while the 364-bp product serves as an internal control for both mutant and normal allele. The percentage of GATA-1neg megakaryocytes according to the presence or not of JAK2 mutation is reported in D.